| Literature DB >> 30671902 |
Graeme L Close1, Andreas M Kasper2, James P Morton2.
Abstract
Sport nutrition is one of the fastest growing and evolving disciplines of sport and exercise science, demonstrated by a 4-fold increase in the number of research papers between 2012 and 2018. Indeed, the scope of contemporary nutrition-related research could range from discovery of novel nutrient-sensitive cell-signalling pathways to the assessment of the effects of sports drinks on exercise performance. For the sport nutrition practitioner, the goal is to translate innovations in research to develop and administer practical interventions that contribute to the delivery of winning performances. Accordingly, step one in the translation of research to practice should always be a well-structured critique of the translational potential of the existing scientific evidence. To this end, we present an operational framework (the "Paper-2-Podium Matrix") that provides a checklist of criteria for which to prompt the critical evaluation of performance nutrition-related research papers. In considering the (1) research context, (2) participant characteristics, (3) research design, (4) dietary and exercise controls, (5) validity and reliability of exercise performance tests, (6) data analytics, (7) feasibility of application, (8) risk/reward and (9) timing of the intervention, we aimed to provide a time-efficient framework to aid practitioners in their scientific appraisal of research. Ultimately, it is the combination of boldness of reform (i.e. innovations in research) and quality of execution (i.e. ease of administration of practical solutions) that is most likely to deliver the transition from paper to podium.Entities:
Mesh:
Year: 2019 PMID: 30671902 PMCID: PMC6445818 DOI: 10.1007/s40279-018-1005-2
Source DB: PubMed Journal: Sports Med ISSN: 0112-1642 Impact factor: 11.136
Fig. 1Translation of science to practice: a map of delivery towards improved performance outcomes. In this model, the quality of research is ranked according to the degree of innovation and translational potential whilst practical application is ranked according to the development, delivery and ease of administration of practical strategies. In the absence of developments in research and innovation or alterations to the practical application of the existing science, performance remains as status quo (Quadrant 1). Developments in research and innovation (especially research with translational potential) but without concomitant changes to practical application merely lead to an ‘increased potential’ to deliver improved performance outcomes (Quadrant 2). In contrast, continual improvements in the practical application of existing science are likely to lead to improved performance outcomes (Quadrant 3). Finally, the pursuit of research-informed practice and development of research-active practitioners (who also possess the skill attributes outlined in Quadrant 3) alongside continual improvements in quality of practical application may deliver transformational improvements in performance outcomes (Quadrant 4). CHO carbohydrate
The Paper-2-Podium (P-2-P) Matrix: an operational framework to evaluate the translational potential of performance nutrition research
| Score | − 2 | − 1 | 0 | + 1 | + 2 |
|---|---|---|---|---|---|
| Research context | Non-human cells and no exercise condition (mechanistic study) | Non-human cells but exercise condition (mechanistic study) | Human cell type in vitro study (mechanistic study) | Human participants and exercise performance measures (applied study) | Human participants, exercise performance measures and evaluation of mechanisms (applied and mechanistic study) |
| Research participants | Levels of participants not reported | Inappropriate age group or training status for the context required | Inappropriate training status of the participants for the context required (with defined criteria) although in required age group | Close to appropriate training status for the context required. e.g. trained level participants when wanting to translate to elite athletes (with defined criteria), and in the required age group | The same training status for the context required, e.g. elite level participants when wanting to translate to elite athletes (with defined criteria) and in required age group |
| Research design | No control group and no blinding of intervention. No consideration of sample size | Randomisation of participant allocation to treatment in matched pairs design, inclusion of control group but no blinding of intervention. No consideration of sample size | Randomised cross-over trial with repeated measures or matched groups design, inclusion of control group but no blinding of intervention. Sample size commensurate with previous research in the area but no sample size calculations provided | Randomised cross over trial with repeated measures or matched groups design with single blind placebo- controlled conditions. Sample size commensurate with previous research in the area but no sample size calculations provided | Randomised cross over trial with repeated measures or matched groups and double- blind placebo- controlled conditions. A priori sample size calculation provided and justified |
| Dietary and exercise controls | No reference to dietary or exercise controls | Methods of dietary and exercise control cited (but limited to subject self-reporting) and no objective data provided | Methods of dietary and exercise control cited (but limited to subject self-reporting) supported by relevant objective data | Dietary provision provided by researchers, exercise control cited, supported by relevant objective data but limited replication to real-world context | Dietary provision provided by researchers, exercise control cited, supported by relevant objective data and representative of real-world context |
| Validity and reliability | No inclusion of familiarisation trial or citation of reliability data and measurement tool error. Exercise protocol not representative of the relevant exercise modality nor valid to real-world context | Inclusion of familiarisation trial but no citation of reliability data or measurement tool error. Exercise protocol not representative of the relevant exercise modality nor valid to real-world context | Inclusion of familiarisation trial and citation of reliability data and measurement tool error. Exercise protocol not representative of the relevant exercise modality nor valid to real-world context | Inclusion of familiarisation trial and citation of reliability data and measurement tool error. Exercise protocol is representative of the relevant exercise modality but limited to a laboratory- based protocol that is not valid to real-world context | Inclusion of familiarisation trial and citation of reliability data and measurement tool error. Exercise protocol is representative of the relevant exercise modality and includes both laboratory- and field- based protocols that are applicable to real-world context |
| Data analytics | Analytics not reported or performed | Analytics reported but limited to descriptive statistics | Analytics reported and appropriate significance or MBI tests provided | Analytics reported, appropriate significance or MBI tests provided and effect sizes included | Analytics reported, appropriate significance or MBI tests provided, effect sizes included and presentation of individual responses to treatment intervention if appropriate |
| Having assessed the relevant paper from a research design perspective, the below criteria evaluate the feasibility of application in relation to the practitioner’s chosen sporting context | |||||
| Feasibility of application | Outside the budget constraints of the organisation. Complex to implement, e.g. daily long term supplementation and low chance of compliance | Could be within budget constraints but complex to implement and low chance of compliance | Within budget constraints, reasonable to implement and some chance of compliance | Cheap to implement, simple to implement and good chance of compliance | Cheap to implement, extremely simple to implement and minimal risk of non-compliance |
| Risk/reward | High risk in terms of anti-doping violation or safety of the intervention. No safety data available. Potential to impair performance through high risk of adverse side effects. Optimum dose not stated or unknown | Minimal risk in terms of anti-doping violation but no safety data available. Potential to impair performance through high risk of adverse side effects. Optimum dose not stated or unknown | Minimal risk in terms of anti-doping violation and safety data available. Some potential side effects, e.g. GI discomfort that may reduce performance. Optimal dose suggested but unclear | Minimal risk in terms of anti-doping violation and safety data available. Low risk of side effects that may reduce performance. Optimal dose suggested but unclear | Minimal risk in terms of anti-doping violation and safety data available. Solid evidence of no side effects and optimal dose clear |
| Timing of intervention | Not age-appropriate. Time available for dosing is not suitable and/or is too close to the major competition to warrant testing the new strategy | Age-appropriate for the athlete. Time available for dosing is not suitable and/or is too close to the major competition to warrant testing the new strategy | Age-appropriate for the athlete. Time available for dosing is not considered optimal but could be effective. Time from the major competition is not sufficient to warrant testing the new strategy | Age-appropriate for the athlete. Time available for dosing is not considered optimal but could be effective. Time from the major competition is sufficient to warrant testing the new strategy. | Age-appropriate for the athlete. |
| Scores | Negative score | 0 score—low positive | Moderate to high positive score | ||
Where relevant, the P-2-P Matrix should be used alongside the supporting text in the paper to accommodate the nuances inherent to performance nutrition related research
GI gastrointestinal, MBI magnitude-based inference
Evaluation of three research papers utilising the Paper-2-Podium Matrix
| Criteria | Paper #1 | Paper #2 | Paper #3 |
|---|---|---|---|
| Kasper et al. [ | Cobley et al. [ | Gomez-Cabrera et al. [ | |
| Research context | + 1 | + 1 | − 1 |
| Research participants | + 1 | + 1 | − 2 |
| Research design | + 1 | + 2 | 0 |
| Dietary and exercise controls | + 1 | − 1 | 0 |
| Validity and reliability | + 1 | − 1 | − 1 |
| Data analytics | + 1 | 0 | 0 |
| Feasibility of application | + 1 | 0 | + 1 |
| Risk/reward | + 1 | − 2 | -1 |
| Timing of intervention | + 2 | + 2 | + 2 |
| Total score/interpretation | + 10 | + 2 | − 2 |
In this scenario the papers were assessed in the context of their translational ability to adult elite athletes. When considering ‘Timing of intervention’ we have assumed that the intervention is age-appropriate, the time available for dosing is considered optimal to be effective, and that the time from major competition is sufficient to warrant testing the new strategy
CHO carbohydrate, MBI magnitude-based inference
| The field of sport nutrition has evolved substantially during the last two decades and now encompasses a range of research examining the effects of nutrient availability on modulating cell-signalling pathways through to the more traditional evaluations of ergogenic aids on performance. |
| The task of translating research to practical interventions to implement in athletic populations has therefore become highly complex, requiring a critical evaluation of the translational potential of the research in question as well as the feasibility of application with specific athletes and sporting domains. |
| To this end, we present the Paper-to-Podium Matrix, a nine-stage decision-making process to evaluate the translational potential of performance nutrition-related research according to traditional research design indices and feasibility of application. |